Related Experiment Video
Updated: Jul 5, 2026

Using Unidirectional Rotations to Improve Vestibular System Asymmetry in Patients with Vestibular Dysfunction
Published on: August 30, 2019
A clinical epidemiological study in 2169 patients with vertigo
Min Yin1, Kazuo Ishikawa, Weng Hoe Wong
1Division of Otorhinolaryngology, Head and Neck Surgery, Department of Sensory Medicine, Akita University School of Medicine, Hondo 1-1-1, Akita 010-8543, Japan.
This study analyzed 2169 vertigo patients, revealing diverse causes and a peak incidence in the 1960s. Elderly individuals showed a higher risk of central vertigo.
Area of Science:
- Clinical Epidemiology
- Neurology
- Otolaryngology
Background:
- Vertigo is a common condition with numerous potential causes.
- Understanding its epidemiological characteristics is crucial for effective diagnosis and management.
Purpose of the Study:
- To investigate the clinical epidemiological characteristics of vertigo.
- To identify patterns in vertigo incidence across different age groups and genders.
Main Methods:
- Retrospective study of 2169 patients diagnosed with vertigo over 20 years.
- Data collection included patient demographics, vertigo classification (peripheral, central, unclassified, unknown), and age-specific incidence.
Main Results:
- Over 50 causative diseases were identified.
- Peripheral vertigo was most common (33.8%), followed by unclassified (26.8%), unknown origin (22.2%), and central vertigo (17.2%).
- Incidence increased with age, peaking in the 1960s; elderly patients had a higher risk of central vertigo. No significant gender difference was found.
Conclusions:
- Vertigo affects all age groups, with diverse underlying etiologies.
- Age is a significant factor in vertigo incidence and type, with a notable increase in central vertigo among the elderly.
Related Concept Videos
Equilibrium and Balance
Hypertension III: Clinical Manifestations and Diagnostic Studies
The Vestibular System
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Bioavailability Study Design: Healthy Subjects Versus Patients
